Alopecia areata becomes a real category
Approved JAK inhibitors have turned alopecia areata into an actual prescribing category.
Alopecia areata has had no systemic option for most of its modern history. Approved JAK inhibitors have changed that, and the cosmetic-versus-medical framing is being renegotiated as a result.
Continue reading
Full intelligence on PanaceaIntel
PatientSpotlight publishes the headline framing. The full brief, the editorial takeaway, and the source list sit on PanaceaIntel for entitled clients.
New to PanaceaIntel? Request access and the team will reply within one working day.
Related
- ExplainedWhat is lupus nephritis?
- SnapshotLupus nephritis therapy reference (2026)
- ExplainedWhat is Sjogren disease?
- ExplainedWhat is ANCA-associated vasculitis?
← Back to Signals
Published by PatientSpotlight, by PanaceaIntel.